Martin Alexander Gershon | Managing Partner
Endeavor Life Science Venture Fund

Martin Alexander Gershon, Managing Partner, Endeavor Life Science Venture Fund

Dr. Martin Alexander Gershon, MD, JD, MPH is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds and Venture Studio, Senior Executive Investor-in-Residence for Healthcare at Techstars, Host of the BetterHealth Webinar Series, and contributing writer for Fast Company on healthcare venture capital and entrepreneurship.
He has been honored by Standard and Poor’s as a designated Top 100 “Healthcare Industry Leader”, recognized by Linkedin as a “Top Voice” in Venture Capital and Entrepreneurship, is an award winning Google Scholar in Entrepreneurship, and has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs in drug discovery, biotechnology and AI and digital healthcare. 
Over the past 23 years he founded 6 startups, lead Endeavor Venture Funds to over 100 investments, has served as Senior Strategic Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, BlackRock, American Express, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, and Novartis, and has developed Endeavor into a thriving ecosystem of investing, advising and partnerships with BioPharma, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, Oxford, McGill and Johns Hopkins.
Dr. Gershon is the former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard, McGill and Columbia trained neuroscientist, oncologist and immunologist, Senior Lecturer of Healthcare Economics and Entrepreneurship at Johns Hopkins, Professor of Healthcare Policy and Finance at Columbia, Professor of Healthcare Innovation and Entrepreneurship at McGill,  Guest Lecturer of Drug Development and Drug Discovery at Harvard and MIT, Guest Lecturer of Healthcare AI and Digital Innovation and Commercialization at NYU and Johns Hopkins, Executive-in-Residence at Matter Health, Chief Innovation and Investment Officer of Life Sciences at McGill CLIP, Special Advisor to the Dean of the McGill University School of Medicine for licensing and commercialization, and former FDA attorney specializing in clinical trials and drug and device approvals.

Appearances:



Day 1 (26th June) @ 10:15

First round pitches

First round of start-up pitches at start-up theatre on exhibition floor 

10.15-10.25 – Chair intro: Alexander Böser, Senior Ecosystem Manager, 5-HT Chemistry & Health

Judges:  Georg Hinkel, Professor, The RheinMain University of Applied Science

David Volpato, Product owner, EF Education First

Alice Freton, Start up Program Manager, Innovation Office, University of Basel

Martin Alexander Gershon, Managing Partner and CIO, Endeavor Venture Funds & Venture Studio

 

Day 1 (26th June) @ 17:00

Second round start up pitches

Second round of start-up pitches at start-up theatre on exhibition floor 17.00-18.00

Day 2 (27th June) @ 14:45

Assessing the landscape for AI- industry trends and where is investment going?

last published: 17/Jun/24 14:15 GMT

back to speakers

GET INVOLVED

INVOLVIERT WERDEN

For conference production and speaking opportunites:

Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:

ellie.whitehead@terrapinn.com 

For sponsorship and exhibition opportunities:

Shilpa.Suthar@terrapinn.com